Saturday, 31 October 2026European Markets

SANDNES SPAREBANK, VALUE8 CUM PREF, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - sandnes sparebank (sadg.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
sandnes sparebank (sadg.ol) kr95.50 7.85% 10.15%
value8 cum pref (preva.as) €5.00 7.09% 6.16%
crcam morbihan cci (cmo.pa) €58.04 4.6% 2.7%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sandnes sparebank (sadg.ol)

7.85% forward dividend yield and 10.15% return on equity

sandnes sparebank, an independent savings bank, provides a range of banking and investment products to retail and corporate customers in norway. it operates through three segments: retail market, corporate market, and real estate. the company offers fixed rate deposits, deposit accounts, bsu, and tax withholding and other accounts; child, death, income, critical illness, disability, car, home, cabin, contents, ung, and other insurance products; and pension solutions. it also provides bank guarantee, overdrafts, leasing, construction and business loans, factoring and invoice sales; fixed interest, mortgage, car, and other vehicle loans, as well as small loans and refinancing, and green loans; bank and credit cards; various loans and guarantees; and mobile and internet banking services. in addition, the company offers real estate brokerage and general investment advisory services. sandnes sparebank was founded in 1875 and is headquartered in sandnes, norway.

earnings per share

as for profitability, sandnes sparebank has a trailing twelve months eps of kr10.8.

pe ratio

sandnes sparebank has a trailing twelve months price to earnings ratio of 8.84. meaning, the purchaser of the share is investing kr8.84 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.15%.

sales growth

sandnes sparebank's sales growth for the next quarter is 6.8%.

yearly top and bottom value

sandnes sparebank's stock is valued at kr95.50 at 12:30 est, way under its 52-week high of kr106.98 and way above its 52-week low of kr79.20.

growth estimates quarters

the company's growth estimates for the present quarter is 24.2% and a drop 18.6% for the next.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on apr 11, 2024, the estimated forward annual dividend rate is 7.5 and the estimated forward annual dividend yield is 7.85%.

more news about sandnes sparebank.

2. value8 cum pref (preva.as)

7.09% forward dividend yield and 6.16% return on equity

value8 n.v. is a private equity firm specializing in middle market, buyout, add-on and growth capital investments in small and medium-sized companies. the firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. it typically invests in western europe, primarily in the netherlands, belgium and france. the firm considers investments in companies with an enterprise value between €10 million ($10.74 million) and €150 million ($208.87 million). the firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. value8 nv was founded in 2008 and is headquartered in bussum, netherlands.

earnings per share

as for profitability, value8 cum pref has a trailing twelve months eps of €1.869.

pe ratio

value8 cum pref has a trailing twelve months price to earnings ratio of 2.68. meaning, the purchaser of the share is investing €2.68 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.16%.

more news about value8 cum pref.

3. crcam morbihan cci (cmo.pa)

4.6% forward dividend yield and 2.7% return on equity

caisse régionale de crédit agricole du morbihan provides various banking products and services to individuals, private banking, professionals, farmers, associations, businesses, and public community and social housing in france. the company offers bank and savings accounts; term savings, treasury and project management; bank cards, collection solutions, lease financing, health payment solutions, leasing, mobile payments; medium and long term, real estate, consumer, and vehicle loans; and work and medium term credits. it also provides real estate, financial, cash, community, social housing, responsible, and short medium term investments; and community and social housing cash flows services. in addition, the company offers home, large residences home, rental guarantee, car, motorcycle, scooter, classic vehicle, funeral, death, dependence, supplementary health, life accident, civil liability, legal protection, all mobile, consumer credit and home loan borrower, welfare, association, employee, borrow, life, pension, health, and other insurance products, as well as agricultural building, equipment, and activity insurances. caisse régionale de crédit agricole du morbihan was founded in 1904 and is headquartered in vannes, france. caisse régionale de crédit agricole du morbihan operates as a subsidiary of crédit agricole s.a.

earnings per share

as for profitability, crcam morbihan cci has a trailing twelve months eps of €13.49.

pe ratio

crcam morbihan cci has a trailing twelve months price to earnings ratio of 4.3. meaning, the purchaser of the share is investing €4.3 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.7%.

more news about crcam morbihan cci.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com